One document that has been getting a lot of attention on social media is the drug maker’s “Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021”, with the numbers referring to the Pfizer-BioNTech COVID-19 vaccine. It contains cumulative post-authorization safety data. The document notes that Pfizer’s safety database records adverse events that are reported to the manufacturer, published in medical literature, and reported by health authorities, among other sources.
It contains a chart showing some of the most commonly reported adverse events following vaccination, and the top classifications were general disorders, nervous system, musculoskeletal, gastrointestinal and skin related, although cardiac, vascular, psychiatric and many other categories also appeared. When it came to events reported in more than 2% of cases, tachycardia, myalgia, nausea, fatigue and numerous others were listed.
There was also a shockingly long list of adverse events of special interest (AESI), which are medical concerns specific to a vaccine or medication that require close monitoring during and after clinical trials. Rather than serving as an official list of side effects, its purpose is safety surveillance, but the fact that there are so many of them should give everyone serious pause.
The appendix contains a full NINE pages of adverse events of special interest. It is so lengthy that it might have been easier for them to list the side effects they weren’t concerned about monitoring.
Journalist Naomi Wolf recently released an exposé on the serious injuries related to COVID-19 vaccines that Pfizer and the FDA were already well aware of in early 2021 but obscured from the public.
In “The Pfizer Papers: Pfizer’s Crimes Against Humanity,” she detailed the full scope of the effects of the jab with help from scientists and doctors who scoured data from Pfizer and public reporting systems.
Wolf has long been skeptical of the vaccines and was deplatformed from every social media platform she used after tweeting her worries about the many women who experienced menstrual dysregulation following the jab.
She has now gone from working for liberal legacy media outlets to working on her own to keep Americans informed. She said that the reports her group studied made it clear that Pfizer knew about the vaccines’ many dangers but pressed forward anyway, and so did the FDA.
“In other words, damaging humans in very specific ways, very early on, was obviously a result of these injections. And instead of stopping, or pulling them off the market, Pfizer doubled down, the FDA doubled down and the CDC [Centers for Disease Control and Prevention] doubled down,” she told The Defender.
In fact, she said that they did this even though they knew more than 1,200 people died from the jabs during the first three months and that it caused serious side effects in tens of thousands of individuals while doing nothing to stop infection.
She also drew attention to what she said was “one of the most damning reports in this book” about Pfizer manipulating data to gain the FDA’s support for an emergency use authorization (EUA). In the report, an Australian anesthesiologist and his team found that Pfizer postponed recording deaths so they would not have to include them in their EUA data filing; had they done so, the EUA would not have been granted.
According to the Pfizer Papers, nearly 160,000 adverse events were reported to the pharmaceutical company in the first three months after it was given its EUA. There were so many reports that Pfizer had to take on 600 more employees to process them.
These effects weren’t minor issues like headaches or pain at the injection site. Wolf noted: “These are tens of thousands of blood clots, lung clots, leg clots, neurological disorders, epilepsies, dementia, Alzheimer’s, bell’s palsy, tremors, convulsions, liver damage, kidney damage, stroke, so many kinds of skin eruptions, eye damage, blindness, respiratory illness.”
The worst effects, however, were on women, who accounted for 72% of the adverse events reported.
Sources for this article include: